This activity is expired and is no longer available for CME credit.


Can Response to Bevacizumab for DME Be Predicted in the Fellow Eye?

Author(s)/Faculty: Peter Karth, MD
Release Date: 5/25/2012Expiration Date: 5/24/2015
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: Provider:
Identifying factors that can aid in predicting the response to intravitreal bevacizumab in the fellow eye based on the response to treatment in the first eye may assist clinicians in the decision to institute or abandon treatment in the setting of CSDME. Our data indicates that the response to bevacizumab in the fellow eye is partially explained by the response in the first eye to bevacizumab and by the pre-injection CFT in the fellow eye. Lens status, change in visual acuity, and age were not statistically significant predictors of response...